Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women

dc.contributor.authorMuñoz, Nubia
dc.contributor.authorHernandez-Suarez, G.
dc.contributor.authorMéndez, F.
dc.contributor.authorMolano, Monica
dc.contributor.authorPosso, H.
dc.contributor.authorMoreno Aguado, Víctor
dc.contributor.authorMurillo, R.
dc.contributor.authorRonderos, M.
dc.contributor.authorMeijer, Chris J. L. M.
dc.contributor.authorMuñoz, Á.
dc.contributor.authorINC HPV Study Group
dc.date.accessioned2018-03-19T10:25:24Z
dc.date.available2018-03-19T10:25:24Z
dc.date.issued2009-04-07
dc.date.updated2018-03-19T10:25:24Z
dc.description.abstractLittle is known about the dynamics of human papillomavirus (HPV) infection and subsequent development of high-grade cervical intraepithelial neoplasia (CIN2/3), particularly in women >30 years of age. This information is needed to assess the impact of HPV vaccines and consider new screening strategies. A cohort of 1728 women 15-85 years old with normal cytology at baseline was followed every 6 months for an average of 9 years. Women with squamous intraepithelial lesions were referred for biopsy and treatment. The Kaplan-Meier method was used to estimate the median duration of infection and Cox regression analysis was undertaken to assess determinants of clearance and risk of CIN2/3 associated with HPV persistence. No difference in the likelihood of clearance was observed by HPV type or woman's age, with the exception of lower clearance for HPV16 infection in women under 30 years of age. Viral load was inversely associated with clearance. In conclusion, viral load is the main determinant of persistence, and persistence of HPV16 infections carry a higher risk of CIN2/3.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec575079
dc.identifier.issn0007-0920
dc.identifier.pmid19293802
dc.identifier.urihttps://hdl.handle.net/2445/120856
dc.language.isoeng
dc.publisherCancer Research UK
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/sj.bjc.6604972
dc.relation.ispartofBritish Journal of Cancer, 2009, vol. 100, num. 7, p. 1184-1190
dc.relation.urihttps://doi.org/10.1038/sj.bjc.6604972
dc.rightscc-by-nc-sa (c) Muñoz, N. et al., 2009
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationPapil·lomavirus
dc.subject.classificationVacuna del papil·lomavirus
dc.subject.classificationColl uterí
dc.subject.classificationTumors
dc.subject.classificationFactors de risc en les malalties
dc.subject.classificationDones
dc.subject.classificationColòmbia
dc.subject.otherPapillomaviruses
dc.subject.otherPapillomavirus vaccines
dc.subject.otherCervix uteri
dc.subject.otherTumors
dc.subject.otherRisk factors in diseases
dc.subject.otherWomen
dc.subject.otherColombia
dc.titlePersistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
575079.pdf
Mida:
136.73 KB
Format:
Adobe Portable Document Format